Company / Current Liabilities per Share
Spyre Therapeutics, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.97
FY2025
5-year range
$0.30 / $12.23
FY2021-FY2025
Trend
-35.0%
vs FY2024
Sector context
#116 of 210
Health Care
What the data says
At $0.97, Spyre Therapeutics, Inc.'s current liabilities per share ranks #95 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.30 in FY2022 to $12.23 in FY2023.
Based on SEC 10-K filings.
0.97 in FY2025 with a 5-year CAGR of +11.5%.
Improved from $12.23 to $0.97 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +48.6%
- 5-Year CAGR
- +11.5%
- 10-Year CAGR
- -
Sector benchmark
-95.9% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 35.0% year-over-year.
- Ranks #116 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2023.
- Lowest current liabilities per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.97 | -35.0% |
| FY2024 | $1.50 | -87.7% |
| FY2023 | $12.23 | +4019.6% |
| FY2022 | $0.30 | -29.3% |
| FY2021 | $0.42 | -25.7% |
| FY2020 | $0.57 | -25.7% |
| FY2019 | $0.76 | +23.8% |
| FY2018 | $0.61 | +65.1% |
| FY2017 | $0.37 | -8.1% |
| FY2016 | $0.40 | -90.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026